Arrhythmias

The FDA ( Food and Drug Administration ) has approved Farydak ( Panobinostat, previously known as LBH589 ) capsules in...


Heart failure is a common condition in elderly patients. Despite great improvements in medical therapy, heart failure mortality remains high....


Flecainide ( Almarytm, Tambocor ) is frequently used for treatment of cardiac arrhythmias in children. Due to concerns regarding increased...


Whether culture-expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy is...


This assessment updates and expands on two previous technology assessments that evaluated implantable cardioverter defibrillators ( ICDs ) for arrhythmias...


Health professionals are reminded of the risks of accidental exposure to or ingestion of Fentanyl patches, especially for children. Fentanyl is...


Health professionals are advised that the Product Information for Quetiapine has been updated to include additional information regarding risks of...


Left atrial fibrosis is prominent in patients with atrial fibrillation ( AF ). Extensive atrial tissue fibrosis identified by delayed...


Atrial fibrillation is the most common rhythm disorder seen in clinical practice. Antiarrhythmic drugs are effective for reduction of recurrence...


In final draft guidance NICE ( National Institute for Health and Care Excellence ) has defined which heart devices (...


A study has assessed safety and cardiovascular outcomes of Dronedarone ( Multaq ) in patients with paroxysmal or persistent atrial...


Empiric circumferential pulmonary vein isolation ( CPVI ) has become the therapy of choice for drug-refractory atrial fibrillation. Although results...


Altered cardiac repolarization and increased dispersion of repolarization have been identified as risk factors for sudden cardiac death ( SCD...


Cerdelga ( Eliglustat ), a novel glucosylceramide analog given orally, was designed to partially inhibit the enzyme glucosylceramide synthase, which...


Up to 10% of patients with high blood pressure are resistant to treatment, which puts them at increased risk of...


Enzyme replacement therapy ( ERT ) is the standard therapy for Fabry disease. Enzyme replacement therapy partially cleared microvascular deposits...


Ondansetron ( brand leader Zofran ) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic...


A study published in the European Heart Journal found no evidence that Digoxin increases mortality in patients with atrial fibrillation...


Digoxin, a drug that has been used worldwide for centuries to treat heart disease, is associated with a significant increase...


Thyroid hormone treatment administered to rats at the time of a myocardial infarction led to significant reduction in the loss...